Phase II Study of Atezolizumab and Cabozantinib in Patients with Metastatic Pancreatic Cancer
The purpose of this phase I trial is to test the safety and feasibility of combination treatment, cabozantinib, and atezolizumab in patients with metastatic pancreatic cancer.
Study ID: 2108097176
Trial Phase: Phase II
Trial Sponsor: University of Arizona
Therapies Used in This Trial: Cabozantinib, Atezolizumab